Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Download

Total Articles

3
(from Reference Citation Analysis)

Article PDFs (0)

Cited by > 0 (0)

Searched Name

Calan

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Publication Title Analysis
Category Analysis

Results Analysis

Indexed Articles

Year Published

Show more Refine

Article Type

Show more Refine

Article Statistics

Refine

MESH Headings

Show more Refine

First Author

Show more Refine

First Author Affiliations

Show more Refine

Authors

Show more Refine

Publication Titles

Show more Refine

Grant Agencies

Show more Refine

Countries/Regions

Show more Refine

Affiliations

Show more Refine

Corresponding Author Affiliations

Show more Refine

Category

Show more Refine

Number	Citation Analysis
1	Comparison table: Some drugs for migraine prevention in adults. Med Lett Drugs Ther 2023;65:e100-2. [PMID: 37266989 DOI: 10.58347/tml.2023.1678c] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [Subscribe] [Scholar Register] [Indexed: 06/03/2023] Abstract Collapse Key Words Aimovig Ajovy Atacand Botox Calan Cymbalta Depakote Effexor Emgality Lopressor Nurtec Qulipta SNRIs Topamax Toprol Vyepti adverse effects amitriptyline antiepileptics atogepant beta blockers candesartan divalproex sodium dosage duloxetine efficacy eptinezumab erenumab fremanezumab galcanezumab lisinopril metoprolol migraine nortriptyline onabotulinumtoxinA pregnancy propranolol rimegepant safety timolol topiramate tricylic antidepressants valproate venlafaxine verapamil Collapse MESH Headings Collapse Grants Collapse Affiliation(s) Collapse
2	Drugs for hypertension. Med Lett Drugs Ther 2020;62:73-80. [PMID: 32555118] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/11/2023] Abstract Collapse Key Words ACE inhibitors ARBs Accupril Accuretic Adalat Aldactone Altace Atacand Avalide Avapro Benicar Bystolic Calan Cardizem Cardura CaroSpir Cartia Catapres Coreg Corgard Cozaar Dilt-XR Diovan Diuril Dutoprol Dyrenium Edarbi Edarbyclor Edecrin Epaned Hyzaar Inderal InnoPran Inspra Kapspargo Sprinkle Katerzia Lasix Lopressor Lotensin Matzim Micardis Minipress Norvasc Prinivil Procardia Qbrelis Sular Taztia Tekturna Tenoretic Tenormin Tiadylt Tiazac Toprol Vaseretic Vasotec Verelan Zestoretic Zestril Ziac acebutolol adverse effects aliskiren amiloride amlodipine atenolol azilsartan benazapril beta blockers betaxolol bisoprolol bumetanide calcium-channel blockers candesartan captopril carvedilol chlorthalidone clonidine diltiazem diuretics dosage doxazosin efficacy enalapril eplerenone eprosartan ethacrynic acid felodipine fosinopril furosemide guanfacine hydralazine hydrochlorothiazide hypertension indapamide irbesartan isradipine labetalol lisinopril losartan methyldopa metolazone metoprolol minoxidil moexipril nadolol nebivolol nicardipine nifedipine nisoldipine olmesartan perindopril pindolol prazosin pregnancy propranolol quinapril ramipril safety spironolactone telmisartan terazosin timolol torsemide trandolapril triamterene valsartan verapamil Collapse MESH Headings Antihypertensive Agents/adverse effects Antihypertensive Agents/pharmacology Antihypertensive Agents/therapeutic use Blood Pressure/drug effects Humans Hypertension/drug therapy Hypertension/physiopathology Collapse Grants Collapse Affiliation(s) Collapse
3	Drugs for atrial fibrillation. Med Lett Drugs Ther 2019;61:137-44. [PMID: 31599871] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/10/2023] Abstract Collapse Key Words Antiarrythmic Drugs Beta-adrenergic blockers Betapace Brevibloc Calan Cardizem Cartia Catheter Ablation Coreg Corgard Coumadin DOAC Digitek Digox Eliquis Inderal InnoPran Isoptin Kapspargo Sprinkle Lanoxin Lixiana Lopressor Mephyton Multaq NOAC Norpace Pacerone Pradaxa Praxbind Rate Control Rhythm Control Rythmol Savaysa Sotalol Taztia Tenormin Tiazac Tikosyn Toprol Verelan Xarelto adverse effects amiodarone andexanet alfa anticoagulants apixaban atenolol atrial fibrillation beta blockers bisoprolol calcium-channel blockers carvedilol dabigatran digoxin diltiazem disopyramide dofetilide dosage dronedarone drug interactions edoxaban efficacy esmolol flecainide idarucizumab metoprolol nadolol propafenone propranolol rivaroxaban safety sotalol verapamil vitamin K warfarin weight loss Collapse MESH Headings Adrenergic beta-Antagonists/pharmacokinetics Adrenergic beta-Antagonists/therapeutic use Animals Anti-Arrhythmia Agents/pharmacokinetics Anti-Arrhythmia Agents/therapeutic use Anticoagulants/pharmacokinetics Anticoagulants/therapeutic use Atrial Fibrillation/drug therapy Atrial Fibrillation/epidemiology Atrial Fibrillation/metabolism Calcium Channel Blockers/pharmacokinetics Calcium Channel Blockers/therapeutic use Clinical Trials as Topic/methods Dabigatran/pharmacokinetics Dabigatran/therapeutic use Humans Rivaroxaban/pharmacokinetics Rivaroxaban/therapeutic use Collapse Grants Collapse Affiliation(s) Collapse